Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Sorafenib in Advanced Solid Tumors
NCT01226056Phase 2Suspended
- Sponsor
- Southern Europe New Drug Organization
- Start
- Mar 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in solid tumor (advanced stage), sponsored by Southern Europe New Drug Organization. Started Mar 2009; status: suspended.
02
Drugs
everolimus
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT01226056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226056.